IFNGR1 and hepatocellular carcinoma: In addition, Okada’s group demonstrated increased IFN-γ receptor expression, IFN-γR1, and mainly IFN-γR2 in the hepatocellular carcinoma cell line after treatment with DFO [68], suggesting that IFN-γ could more efficiently perform its protective mechanism under DFO treatment.